SPI Pharma has introduced a new brand identity, including a refreshed visual system, updated brand voice and the tagline, “Let’s solve it together.”
The Wilmington, Delaware-based company said the change is intended to reflect its position as a formulation partner to pharmaceutical and nutraceutical companies. SPI Pharma develops excipients, drug-delivery technologies, vaccine adjuvants and antacid active ingredients.
The rebrand will be formally launched at CPHI Worldwide in Milan, scheduled for Oct. 6-8. The company said the new identity will subsequently be rolled out through its digital channels, customer communications and industry events.
Packaging and other physical materials will transition to the new branding through normal update cycles. SPI Pharma said the change will not affect product performance, quality systems, product specifications or regulatory documentation.
Chief Executive Freek Snieders said the identity update reflects the company’s evolution and its focus on working with customers on formulation challenges. The company said the branding links its scientific and technical work with the patients who ultimately use products developed with its ingredients and technologies.
SPI Pharma operates manufacturing, research and development, and commercial teams internationally. It is headquartered in Wilmington and is part of ABF Ingredients, a division of Associated British Foods plc.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!